Omer Kays Unal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Omer Kays Unal has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Mirza Zafer Dagtas
Department of Orthopedics and Traumatology, Maltepe University, Istanbul, Turkey
6 shared publications - Mehmet Salih Söylemez
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, İSTANBUL ÜMRANİYE SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZ
3 shared publications - Afşar Timuçin Özkut
Department of Orthopedics and Traumatology, Istanbul Medeniyet University, Göztepe Training and Research Hospital, Istanbul, Turkey
2 shared publications David Terence Thomas
Maltepe University Faculty of Medicine, Department of Medical Education, Istanbul, Turkey
2 shared publications- Esat Uygur
Istanbul Medeniyet University, Department of Orthopedics and Traumatology, Istanbul, Turkey; Skåne University hospital, Orthopaedics and Traumatology, Department of Foot & Ankle Surgery, Malmö, Sweden
2 shared publications - Oguz Poyanli
İstanbul Medeniyet Üniversitesi Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi, Ortopedi ve Travmatoloji Ana Bilim Dalı, İstanbul
2 shared publications
Latest Publications
- Open Access
- 29 December 2025
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 37 (2) , 477-488
Medial plating versus newly designed intramedullary nail with distal interlocking system for distal tibia fractures: A biomechanical study with finite element analysis
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.
- 29 December 2025
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 37 (2) , 477-488
Open AccessMedial plating versus newly designed intramedullary nail with distal interlocking system for distal tibia fractures: A biomechanical study with finite element analysis
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.
- Open Access
- 1 January 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (1) , 79-85
Effects of previous exposure to different medications on the clinical course of COVID-19 patients in Istanbul, Turkey
Background/Aim: Multiple studies have investigated the effects of drugs that alter ACE2 expression, such as renin-angiotensin system inhibitors, non-steroidal anti-inflammatory drugs, and thiazolidinediones, on the clinical course of coronavirus disease-2019 (COVID-19). But a consensus has not yet been reached, and it has been stated that they do not have any effect. There are publications in which metformin is associated with low mortality and insulin with high mortality. Data from different parts of the world are important given that the rate of spread of COVID-19 may be related to the expression status of ACE2 or TMPRSS2 receptors or some other unknown genetic factors. This study aims to examine the effects of medications used chronically in the last 6 months before contracting COVID-19 on the clinical course of COVID-19 in a sample of Istanbul, Turkey. Methods: In this retrospective cohort study, which included 525 patients diagnosed with COVID-19 between March and November 2020 from four family health centers in Istanbul, the records of the patients were retrospectively analyzed. In addition to demographic information, all medications chronically used by the patients in the last 6 months before the diagnosis of COVID-19 were noted. The effects of demographic data and medications on the three main endpoints of the study, which were hospitalization, intensive care unit (ICU) admission, and mortality, were analyzed using logistic regression models. Results: Of the 525 COVID-19 patients included in the study, 109 (20.8%) were hospitalized, 18 (3.4%) were treated in ICU, and 11 (2.1%) patients died. Increasing age is associated with hospitalization, ICU admission and mortality. Also, the presence of COVID-19 thoracic computed tomography (CT) findings and polypharmacy was associated with increased hospitalization. Living alone and the presence of COVID-19 thoracic CT findings was associated with increased ICU admission. When adjusted for age and comorbidity, logistic regression models revealed that medications for diabetes mellitus (DM) increased the probability of hospitalization (OR: 3.9, 95% CI 1.2-13.0), and calcium channel blockers (CCBs) increased the probability of ICU admission (OR: 15.8, 95% CI 2.1–120.2) and mortality (OR: 295.1, 95% CI 4.6–18946.6). Conclusion: Previous use of DM medications and CCBs may negatively affect the clinical course of COVID-19. '+st+' Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, et al. Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients. Hypertension. 2021 Mar 3;77(3):833-42. doi: 10.1161/HYPERTENSIONAHA.120.16314. Epub 2021 11 January. PMID: 33423528; PMCID: PMC7884243. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.16314 Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 Aug;584(7821):430-6. doi: 10.1038/s41586-020-2521-4. Epub 2020 8 July. PMID: 32640463; PMCID: PMC7611074. DOI: https://doi.org/10.1038/s41586-020-2521-4 Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020 May;94:91-5. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 12 March. PMID: 32173574; PMCID: PMC7194638. DOI: https://doi.org/10.1016/j.ijid.2020.03.017 Reilev M, Kristensen KB, Pottegård A, Lund LC, Hallas J, Ernst MT, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020 1 October;49(5):1468-81. doi: 10.1093/ije/dyaa140. PMID: 32887982; PMCID: PMC7499657. DOI: https://doi.org/10.1093/ije/dyaa140 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271-80.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 5 March. PMID: 32142651; PMCID: PMC7102627. DOI: https://doi.org/10.1016/j.cell.2020.02.052 Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte-Salles T, et al. Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study. medRxiv [Preprint]. 2020 Jun 12:2020.06.11.20125849. doi: 10.1101/2020.06.11.20125849. Update in: Lancet Digit Health. 2020 Dec 17;: PMID: 32587982; PMCID: PMC7310640. Asiimwe IG, Pushpakom S, Turner RM, Kolamunnage-Dona R, Jorgensen AL, Pirmohamed M. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(12):4534–45. doi: 10.1111/bcp.14927 DOI: https://doi.org/10.1111/bcp.14927 Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, et al. ITA-COVID-19: RAAS inhibitor group. Renin-angiotensin-aldosterone system inhibitors and risk of death in patients hospitalised with COVID-19: a retrospective Italian cohort study of 43,000 patients. Drug Saf. 2020 Dec;43(12):1297-308. doi: 10.1007/s40264-020-00994-5. PMID: 32852721; PMCID: PMC7450482. DOI: https://doi.org/10.1007/s40264-020-00994-5 Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and COVID- 19: a systematic review and meta-analysis. Drug Saf. 2021;44:929-38. doi: 10.1007/S40264-021-01089-5 DOI: https://doi.org/10.1007/s40264-021-01089-5 Drake TM, Fairfield CJ, Pius R, Knight SR, Norman L, Girvan M, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021;3:e498–506. 10.1016/S2665-9913(21)00104-1 Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021 May;9(5):293-303. doi: 10.1016/S2213-8587(21)00050-4. Epub 2021 30 March. PMID: 33798464; PMCID: PMC8009618. DOI: https://doi.org/10.1016/S2213-8587(21)00050-4 Yang W, Sun X, Zhang J, Zhang K. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus. Diabetes Res Clin Pract. 2021;178:108977. 10.1016/J.DIABRES.2021.108977 DOI: https://doi.org/10.1016/j.diabres.2021.108977 Bramante CT, Buse J, Tamaritz L, Palacio A, Cohen K, Vojta D, et al. Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. J Med Virol. 2021 Jul;93(7):4273-9. doi: 10.1002/jmv.26873. Epub 2021 23 March. PMID: 33580540; PMCID: PMC8013587. DOI: https://doi.org/10.1002/jmv.26873 Lalau JD, Al-Salameh A, Hadjadj S, Goronflot T, Wiernsperger N, Pichelin M, et al. CORONADO investigators. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2021 Sep;47(5):101216. doi: 10.1016/j.diabet.2020.101216. Epub 2020 10 December. PMID: 33309936; PMCID: PMC7832745. DOI: https://doi.org/10.1016/j.diabet.2020.101216 Rakhmat II, Kusmala YY, Handayani DR, Juliastuti H, Nawangsih EN, Wibowo A, et al. Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19)-a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2021 May-Jun;15(3):777-82. doi: 10.1016/j.dsx.2021.03.027. Epub 2021 1 April. PMID: 33838614; PMCID: PMC8012165. DOI: https://doi.org/10.1016/j.dsx.2021.03.027 Hariyanto TI, Kurniawan A. Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord. 2021;20:543–50. doi: 10.1007/s40200-021-00777-4. DOI: https://doi.org/10.1007/s40200-021-00777-4 Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020;12:10087–98. doi: 10.18632/aging.103415. DOI: https://doi.org/10.18632/aging.103415 Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;18:. doi: 10.1186/s12916-020-01673-z DOI: https://doi.org/10.1186/s12916-020-01673-z Ren L, Yu S, Xu W, Overton JL, Chiamvimonvat N, Thai PN. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: a meta-analysis. J Cardiol. 2021;77:482–91. 10.1016/J.JJCC.2020.10.015 DOI: https://doi.org/10.1016/j.jjcc.2020.10.015 Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, et al. The effect of prior angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment on coronavirus disease 2019 (covid-19) susceptibility and outcome: a systematic review and meta-analysis. Clin Infect Dis. 2021 1 June;72(11):e901-13. doi: 10.1093/cid/ciaa1592. PMID: 33079200; PMCID: PMC7665377. DOI: https://doi.org/10.1093/cid/ciaa1592 Yu B, Li C, Sun Y, Wang DW. Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab. 2021;33:65-77. doi: 10.1016/j.cmet.2020.11.014 DOI: https://doi.org/10.1016/j.cmet.2020.11.014 Mendez SR, Frank RC, Stevenson EK, Chung M, Silverman MG. Dihydropyridine calcium channel blockers and the risk of severe COVID-19. Chest. 2021;160:89-93. doi: 10.1016/j.chest.2021.01.073 DOI: https://doi.org/10.1016/j.chest.2021.01.073 Jackson BR, Gold JAW, Natarajan P, Rossow J, Neblett Fanfair R, da Silva J, et al. Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with coronavirus disease 2019. Clin Infect Dis. 2021 6 December;73(11):e4141-51. doi: 10.1093/cid/ciaa1459. PMID: 32971532; PMCID: PMC7543323. DOI: https://doi.org/10.1093/cid/ciaa1459 Yan H, Valdes AM, Vijay A, Wang S, Liang L, Yang S, et al. Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID-19: A Large Case-Control Study. Clin. Pharmacol. Ther. 2020;108:1185-94. doi: 10.1002/cpt.2047 DOI: https://doi.org/10.1002/cpt.2047 Chouchana L, Beeker N, Garcelon N, Rance B, Paris N, Salamanca E, et al. AP-HP/Universities/Inserm COVID-19 research collaboration, AP-HP Covid CDR Initiative, and “Entrepôt de Données de Santé” AP-HP Consortium”. Association of antihypertensive agents with the risk of in-hospital death in patients with COVID-19. Cardiovasc Drugs Ther. 2022 Jun;36(3):483-8. doi: 10.1007/s10557-021-07155-5. Epub 2021 17 February. Erratum in: Cardiovasc Drugs Ther. 2021 Mar 4;: PMID: 33595761; PMCID: PMC7887412. DOI: https://doi.org/10.1007/s10557-021-07164-4 Kow CS, Ramachandram DS, Hasan SS. Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis. Hypertens Res. Published Online First. 2021 doi: 10.1038/s41440-021-00786-z DOI: https://doi.org/10.1038/s41440-021-00786-z Dietl P, Haller T, Frick M. Spatio-temporal aspects, pathways and actions of Ca2+ in surfactant secreting pulmonary alveolar type II pneumocytes. Cell Calcium. 2012;52:296–302. doi: 10.1016/J.CECA.2012.04.010 DOI: https://doi.org/10.1016/j.ceca.2012.04.010 Lodhi FAK, Shogren SL, Vedre JG, Haque N, Reriani M, Ali R. Calcium channel blocker toxicity causing acute respiratory distress syndrome: a commonly used drug triggering a life-threatening condition. Wis Med J. 2020;119:66–8. Alsagaff MY, Mulia EPB, Maghfirah I, Luke K, Nugraha D, Rachmi DA, et al. Association of calcium channel blocker use with clinical outcome of COVID-19: a meta-analysis. Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102210. doi: 10.1016/j.dsx.2021.102210. Epub 2021 16 July. PMID: 34298269; PMCID: PMC8282943. DOI: https://doi.org/10.1016/j.dsx.2021.102210 Magdalan J, Antończyk A, Kowalski K, Przewłocki M, Kochman K, Wasylko-Smolarek M. Severe pulmonary complications of massive intoxication with calcium channel blockers and isosorbide mononitrate-a case report. Przegl Lek. 2004;61:405–7. Humbert VH, Munn NJ, Hawkins RF. Noncardiogenic pulmonary edema complicating massive diltiazem overdose. Chest. 1991, 99:258–9. doi: 10.1378/CHEST.99.1.258 DOI: https://doi.org/10.1378/chest.99.1.258 Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020, 323:2329-30. 10.1001/JAMA.2020.6825 DOI: https://doi.org/10.1001/jama.2020.6825 Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016 Nov 12;388(10058):2416-2430. doi: 10.1016/S0140-6736(16)00578-X. Epub 2016 28 April. Erratum in: Lancet. 2016 Nov 12;388(10058):2354. PMID: 27133972; PMCID: PMC7138018. DOI: https://doi.org/10.1016/S0140-6736(16)00578-X Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981;304:1582-5. doi: 10.1056/NEJM198106253042606 DOI: https://doi.org/10.1056/NEJM198106253042606 Mishra A, Reed RM, Eberlein M. Severe, rapidly reversible hypoxemia in the early period after bilateral lung transplantation. Ann Am Thorac Soc. 2016;13:979–85. 10.1513/ANNALSATS.201602-107CC/SUPPL_FILE/DISCLOSURES.PDF DOI: https://doi.org/10.1513/AnnalsATS.201602-107CC D’elia JA, Weinrauch LA. Calcium ion channels: roles in infection and sepsis mechanisms of calcium channel blocker benefits in immunocompromised patients at risk for infection. Int J Mol Sci. 2018, 19:1–17. 10.3390/ijms19092465 DOI: https://doi.org/10.3390/ijms19092465 Crespi B, Alcock J. Conflicts over calcium and the treatment of COVID-19. Evol Med Public Heal. 2020, 9:149–56. doi: 10.1093/EMPH/EOAA046 DOI: https://doi.org/10.1093/emph/eoaa046 Straus MR, Bidon MK, Tang T, Jaimes JA, Whittaker GR, Daniel S. Inhibitors of L-type calcium channels show therapeutic potential for treating SARS-CoV-2 infections by preventing virus entry and spread. ACS Infect Dis. Published Online First. 2021, 7:2807-2815. 10.1021/ACSINFECDIS.1C00023 DOI: https://doi.org/10.1021/acsinfecdis.1c00023 Silva IVG, De Figueiredo RC, Rios DRA. Effect of different classes of antihypertensive drugs on endothelial function and inflammation. Int J Mol Sci. 2019;20:5–9. 10.3390/ijms20143458 DOI: https://doi.org/10.3390/ijms20143458 Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3:2019686-2019686. 10.1001/JAMANETWORKOPEN.2020.19686 DOI: https://doi.org/10.1001/jamanetworkopen.2020.19686 Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020 23 June;9:636. doi: 10.12688/f1000research.24457.1. PMID: 33093946; PMCID: PMC7549174. DOI: https://doi.org/10.12688/f1000research.24457.1 Şenkal N, Meral R, Medetalibeyoğlu A, Konyaoğlu H, Kose M, Tukek T. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19. Anatol J Cardiol. 2020;24:21-9. doi: 10.14744/ANATOLJCARDIOL.2020.57431. DOI: https://doi.org/10.14744/AnatolJCardiol.2020.57431 Copyright (c) 2023 Ülkü Sur Ünal , Hasan Raci Yananlı , Ömer Kays Ünal , Yasemin Doğan Kaya , Merve Keskin , Fikriye Güngören , Atila Karaalp This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
- 1 January 2023
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 7 (1) , 79-85
Open AccessEffects of previous exposure to different medications on the clinical course of COVID-19 patients in Istanbul, Turkey
Background/Aim: Multiple studies have investigated the effects of drugs that alter ACE2 expression, such as renin-angiotensin system inhibitors, non-steroidal anti-inflammatory drugs, and thiazolidinediones, on the clinical course of coronavirus disease-2019 (COVID-19). But a consensus has not yet been reached, and it has been stated that they do not have any effect. There are publications in which metformin is associated with low mortality and insulin with high mortality. Data from different parts of the world are important given that the rate of spread of COVID-19 may be related to the expression status of ACE2 or TMPRSS2 receptors or some other unknown genetic factors. This study aims to examine the effects of medications used chronically in the last 6 months before contracting COVID-19 on the clinical course of COVID-19 in a sample of Istanbul, Turkey. Methods: In this retrospective cohort study, which included 525 patients diagnosed with COVID-19 between March and November 2020 from four family health centers in Istanbul, the records of the patients were retrospectively analyzed. In addition to demographic information, all medications chronically used by the patients in the last 6 months before the diagnosis of COVID-19 were noted. The effects of demographic data and medications on the three main endpoints of the study, which were hospitalization, intensive care unit (ICU) admission, and mortality, were analyzed using logistic regression models. Results: Of the 525 COVID-19 patients included in the study, 109 (20.8%) were hospitalized, 18 (3.4%) were treated in ICU, and 11 (2.1%) patients died. Increasing age is associated with hospitalization, ICU admission and mortality. Also, the presence of COVID-19 thoracic computed tomography (CT) findings and polypharmacy was associated with increased hospitalization. Living alone and the presence of COVID-19 thoracic CT findings was associated with increased ICU admission. When adjusted for age and comorbidity, logistic regression models revealed that medications for diabetes mellitus (DM) increased the probability of hospitalization (OR: 3.9, 95% CI 1.2-13.0), and calcium channel blockers (CCBs) increased the probability of ICU admission (OR: 15.8, 95% CI 2.1–120.2) and mortality (OR: 295.1, 95% CI 4.6–18946.6). Conclusion: Previous use of DM medications and CCBs may negatively affect the clinical course of COVID-19. '+st+' Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, et al. Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients. Hypertension. 2021 Mar 3;77(3):833-42. doi: 10.1161/HYPERTENSIONAHA.120.16314. Epub 2021 11 January. PMID: 33423528; PMCID: PMC7884243. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.16314 Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 Aug;584(7821):430-6. doi: 10.1038/s41586-020-2521-4. Epub 2020 8 July. PMID: 32640463; PMCID: PMC7611074. DOI: https://doi.org/10.1038/s41586-020-2521-4 Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020 May;94:91-5. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 12 March. PMID: 32173574; PMCID: PMC7194638. DOI: https://doi.org/10.1016/j.ijid.2020.03.017 Reilev M, Kristensen KB, Pottegård A, Lund LC, Hallas J, Ernst MT, et al. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020 1 October;49(5):1468-81. doi: 10.1093/ije/dyaa140. PMID: 32887982; PMCID: PMC7499657. DOI: https://doi.org/10.1093/ije/dyaa140 Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271-80.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 5 March. PMID: 32142651; PMCID: PMC7102627. DOI: https://doi.org/10.1016/j.cell.2020.02.052 Morales DR, Conover MM, You SC, Pratt N, Kostka K, Duarte-Salles T, et al. Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study. medRxiv [Preprint]. 2020 Jun 12:2020.06.11.20125849. doi: 10.1101/2020.06.11.20125849. Update in: Lancet Digit Health. 2020 Dec 17;: PMID: 32587982; PMCID: PMC7310640. Asiimwe IG, Pushpakom S, Turner RM, Kolamunnage-Dona R, Jorgensen AL, Pirmohamed M. Cardiovascular drugs and COVID-19 clinical outcomes: a living systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87(12):4534–45. doi: 10.1111/bcp.14927 DOI: https://doi.org/10.1111/bcp.14927 Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, et al. ITA-COVID-19: RAAS inhibitor group. Renin-angiotensin-aldosterone system inhibitors and risk of death in patients hospitalised with COVID-19: a retrospective Italian cohort study of 43,000 patients. Drug Saf. 2020 Dec;43(12):1297-308. doi: 10.1007/s40264-020-00994-5. PMID: 32852721; PMCID: PMC7450482. DOI: https://doi.org/10.1007/s40264-020-00994-5 Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and COVID- 19: a systematic review and meta-analysis. Drug Saf. 2021;44:929-38. doi: 10.1007/S40264-021-01089-5 DOI: https://doi.org/10.1007/s40264-021-01089-5 Drake TM, Fairfield CJ, Pius R, Knight SR, Norman L, Girvan M, et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. Lancet Rheumatol. 2021;3:e498–506. 10.1016/S2665-9913(21)00104-1 Khunti K, Knighton P, Zaccardi F, Bakhai C, Barron E, Holman N, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021 May;9(5):293-303. doi: 10.1016/S2213-8587(21)00050-4. Epub 2021 30 March. PMID: 33798464; PMCID: PMC8009618. DOI: https://doi.org/10.1016/S2213-8587(21)00050-4 Yang W, Sun X, Zhang J, Zhang K. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus. Diabetes Res Clin Pract. 2021;178:108977. 10.1016/J.DIABRES.2021.108977 DOI: https://doi.org/10.1016/j.diabres.2021.108977 Bramante CT, Buse J, Tamaritz L, Palacio A, Cohen K, Vojta D, et al. Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. J Med Virol. 2021 Jul;93(7):4273-9. doi: 10.1002/jmv.26873. Epub 2021 23 March. PMID: 33580540; PMCID: PMC8013587. DOI: https://doi.org/10.1002/jmv.26873 Lalau JD, Al-Salameh A, Hadjadj S, Goronflot T, Wiernsperger N, Pichelin M, et al. CORONADO investigators. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2021 Sep;47(5):101216. doi: 10.1016/j.diabet.2020.101216. Epub 2020 10 December. PMID: 33309936; PMCID: PMC7832745. DOI: https://doi.org/10.1016/j.diabet.2020.101216 Rakhmat II, Kusmala YY, Handayani DR, Juliastuti H, Nawangsih EN, Wibowo A, et al. Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19)-a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2021 May-Jun;15(3):777-82. doi: 10.1016/j.dsx.2021.03.027. Epub 2021 1 April. PMID: 33838614; PMCID: PMC8012165. DOI: https://doi.org/10.1016/j.dsx.2021.03.027 Hariyanto TI, Kurniawan A. Dipeptidyl peptidase 4 (DPP4) inhibitor and outcome from coronavirus disease 2019 (COVID-19) in diabetic patients: a systematic review, meta-analysis, and meta-regression. J Diabetes Metab Disord. 2021;20:543–50. doi: 10.1007/s40200-021-00777-4. DOI: https://doi.org/10.1007/s40200-021-00777-4 Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging (Albany NY). 2020;12:10087–98. doi: 10.18632/aging.103415. DOI: https://doi.org/10.18632/aging.103415 Hou Y, Zhao J, Martin W, Kallianpur A, Chung MK, Jehi L, et al. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med. 2020;18:. doi: 10.1186/s12916-020-01673-z DOI: https://doi.org/10.1186/s12916-020-01673-z Ren L, Yu S, Xu W, Overton JL, Chiamvimonvat N, Thai PN. Lack of association of antihypertensive drugs with the risk and severity of COVID-19: a meta-analysis. J Cardiol. 2021;77:482–91. 10.1016/J.JJCC.2020.10.015 DOI: https://doi.org/10.1016/j.jjcc.2020.10.015 Xu J, Teng Y, Shang L, Gu X, Fan G, Chen Y, et al. The effect of prior angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment on coronavirus disease 2019 (covid-19) susceptibility and outcome: a systematic review and meta-analysis. Clin Infect Dis. 2021 1 June;72(11):e901-13. doi: 10.1093/cid/ciaa1592. PMID: 33079200; PMCID: PMC7665377. DOI: https://doi.org/10.1093/cid/ciaa1592 Yu B, Li C, Sun Y, Wang DW. Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab. 2021;33:65-77. doi: 10.1016/j.cmet.2020.11.014 DOI: https://doi.org/10.1016/j.cmet.2020.11.014 Mendez SR, Frank RC, Stevenson EK, Chung M, Silverman MG. Dihydropyridine calcium channel blockers and the risk of severe COVID-19. Chest. 2021;160:89-93. doi: 10.1016/j.chest.2021.01.073 DOI: https://doi.org/10.1016/j.chest.2021.01.073 Jackson BR, Gold JAW, Natarajan P, Rossow J, Neblett Fanfair R, da Silva J, et al. Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with coronavirus disease 2019. Clin Infect Dis. 2021 6 December;73(11):e4141-51. doi: 10.1093/cid/ciaa1459. PMID: 32971532; PMCID: PMC7543323. DOI: https://doi.org/10.1093/cid/ciaa1459 Yan H, Valdes AM, Vijay A, Wang S, Liang L, Yang S, et al. Role of Drugs Used for Chronic Disease Management on Susceptibility and Severity of COVID-19: A Large Case-Control Study. Clin. Pharmacol. Ther. 2020;108:1185-94. doi: 10.1002/cpt.2047 DOI: https://doi.org/10.1002/cpt.2047 Chouchana L, Beeker N, Garcelon N, Rance B, Paris N, Salamanca E, et al. AP-HP/Universities/Inserm COVID-19 research collaboration, AP-HP Covid CDR Initiative, and “Entrepôt de Données de Santé” AP-HP Consortium”. Association of antihypertensive agents with the risk of in-hospital death in patients with COVID-19. Cardiovasc Drugs Ther. 2022 Jun;36(3):483-8. doi: 10.1007/s10557-021-07155-5. Epub 2021 17 February. Erratum in: Cardiovasc Drugs Ther. 2021 Mar 4;: PMID: 33595761; PMCID: PMC7887412. DOI: https://doi.org/10.1007/s10557-021-07164-4 Kow CS, Ramachandram DS, Hasan SS. Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis. Hypertens Res. Published Online First. 2021 doi: 10.1038/s41440-021-00786-z DOI: https://doi.org/10.1038/s41440-021-00786-z Dietl P, Haller T, Frick M. Spatio-temporal aspects, pathways and actions of Ca2+ in surfactant secreting pulmonary alveolar type II pneumocytes. Cell Calcium. 2012;52:296–302. doi: 10.1016/J.CECA.2012.04.010 DOI: https://doi.org/10.1016/j.ceca.2012.04.010 Lodhi FAK, Shogren SL, Vedre JG, Haque N, Reriani M, Ali R. Calcium channel blocker toxicity causing acute respiratory distress syndrome: a commonly used drug triggering a life-threatening condition. Wis Med J. 2020;119:66–8. Alsagaff MY, Mulia EPB, Maghfirah I, Luke K, Nugraha D, Rachmi DA, et al. Association of calcium channel blocker use with clinical outcome of COVID-19: a meta-analysis. Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102210. doi: 10.1016/j.dsx.2021.102210. Epub 2021 16 July. PMID: 34298269; PMCID: PMC8282943. DOI: https://doi.org/10.1016/j.dsx.2021.102210 Magdalan J, Antończyk A, Kowalski K, Przewłocki M, Kochman K, Wasylko-Smolarek M. Severe pulmonary complications of massive intoxication with calcium channel blockers and isosorbide mononitrate-a case report. Przegl Lek. 2004;61:405–7. Humbert VH, Munn NJ, Hawkins RF. Noncardiogenic pulmonary edema complicating massive diltiazem overdose. Chest. 1991, 99:258–9. doi: 10.1378/CHEST.99.1.258 DOI: https://doi.org/10.1378/chest.99.1.258 Marini JJ, Gattinoni L. Management of COVID-19 respiratory distress. JAMA. 2020, 323:2329-30. 10.1001/JAMA.2020.6825 DOI: https://doi.org/10.1001/jama.2020.6825 Sweeney RM, McAuley DF. Acute respiratory distress syndrome. Lancet. 2016 Nov 12;388(10058):2416-2430. doi: 10.1016/S0140-6736(16)00578-X. Epub 2016 28 April. Erratum in: Lancet. 2016 Nov 12;388(10058):2354. PMID: 27133972; PMCID: PMC7138018. DOI: https://doi.org/10.1016/S0140-6736(16)00578-X Simonneau G, Escourrou P, Duroux P, Lockhart A. Inhibition of hypoxic pulmonary vasoconstriction by nifedipine. N Engl J Med 1981;304:1582-5. doi: 10.1056/NEJM198106253042606 DOI: https://doi.org/10.1056/NEJM198106253042606 Mishra A, Reed RM, Eberlein M. Severe, rapidly reversible hypoxemia in the early period after bilateral lung transplantation. Ann Am Thorac Soc. 2016;13:979–85. 10.1513/ANNALSATS.201602-107CC/SUPPL_FILE/DISCLOSURES.PDF DOI: https://doi.org/10.1513/AnnalsATS.201602-107CC D’elia JA, Weinrauch LA. Calcium ion channels: roles in infection and sepsis mechanisms of calcium channel blocker benefits in immunocompromised patients at risk for infection. Int J Mol Sci. 2018, 19:1–17. 10.3390/ijms19092465 DOI: https://doi.org/10.3390/ijms19092465 Crespi B, Alcock J. Conflicts over calcium and the treatment of COVID-19. Evol Med Public Heal. 2020, 9:149–56. doi: 10.1093/EMPH/EOAA046 DOI: https://doi.org/10.1093/emph/eoaa046 Straus MR, Bidon MK, Tang T, Jaimes JA, Whittaker GR, Daniel S. Inhibitors of L-type calcium channels show therapeutic potential for treating SARS-CoV-2 infections by preventing virus entry and spread. ACS Infect Dis. Published Online First. 2021, 7:2807-2815. 10.1021/ACSINFECDIS.1C00023 DOI: https://doi.org/10.1021/acsinfecdis.1c00023 Silva IVG, De Figueiredo RC, Rios DRA. Effect of different classes of antihypertensive drugs on endothelial function and inflammation. Int J Mol Sci. 2019;20:5–9. 10.3390/ijms20143458 DOI: https://doi.org/10.3390/ijms20143458 Ettman CK, Abdalla SM, Cohen GH, Sampson L, Vivier PM, Galea S. Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Netw Open. 2020;3:2019686-2019686. 10.1001/JAMANETWORKOPEN.2020.19686 DOI: https://doi.org/10.1001/jamanetworkopen.2020.19686 Hossain MM, Tasnim S, Sultana A, Faizah F, Mazumder H, Zou L, et al. Epidemiology of mental health problems in COVID-19: a review. F1000Res. 2020 23 June;9:636. doi: 10.12688/f1000research.24457.1. PMID: 33093946; PMCID: PMC7549174. DOI: https://doi.org/10.12688/f1000research.24457.1 Şenkal N, Meral R, Medetalibeyoğlu A, Konyaoğlu H, Kose M, Tukek T. Association between chronic ACE inhibitor exposure and decreased odds of severe disease in patients with COVID-19. Anatol J Cardiol. 2020;24:21-9. doi: 10.14744/ANATOLJCARDIOL.2020.57431. DOI: https://doi.org/10.14744/AnatolJCardiol.2020.57431 Copyright (c) 2023 Ülkü Sur Ünal , Hasan Raci Yananlı , Ömer Kays Ünal , Yasemin Doğan Kaya , Merve Keskin , Fikriye Güngören , Atila Karaalp This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
- Open Access
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Acta Ortopedica Brasileira
- Vol. 30 (1) , e246231
A NEW FLUOROSCOPY TECHNIQUE FOR SUPRACONDYLAR HUMERUS FRACTURES
Introduction To compare two different intraoperative fluoroscopy techniques used for closed reduction and percutaneous pinning (CRPP) in pediatric patients with supracondylar humerus fractures (SHF). Materials and Methods Thirty-six patients who underwent SHF surgery from May 2011 to June 2019 were included in the study. During surgery, the classical fluoroscopy method (CFM) was used in 21 patients and the new fluoroscopy method (NFM) was used in the remaining 15 patients. Results The mean age was 5.14±1.13 years in the NFM group and 5.38±1.36 years in the CFM group. Mean operative time was 38.14±5.92 minutes in the CFM group and 21.54±3.48 minutes in the NFM group (p=0.001), while mean fluoroscopy times were 25.65±3.91 seconds and 39.84±7.50 seconds in the NFM and CFM groups, respectively (p=0.001). The NFM and CFM groups demonstrated similar functional capacity as measured by the Mayo Elbow Score (p=0.168). Direct radiographs obtained to measure Baumann’s angle also showed that the two groups had similar results (p=0.848). Conclusions The NFM is a reliable and successful technique as it leads to shorter operative and fluoroscopy times, as well as providing improvement in functional scores and radiological outcomes in short-term follow-up. Level of Evidence III, Therapeutic Studies-Investigating the Results Level of Treatment.
- 1 January 2022
- Published by FapUNIFESP (SciELO) in Acta Ortopedica Brasileira
- Vol. 30 (1) , e246231
Open AccessA NEW FLUOROSCOPY TECHNIQUE FOR SUPRACONDYLAR HUMERUS FRACTURES
Introduction To compare two different intraoperative fluoroscopy techniques used for closed reduction and percutaneous pinning (CRPP) in pediatric patients with supracondylar humerus fractures (SHF). Materials and Methods Thirty-six patients who underwent SHF surgery from May 2011 to June 2019 were included in the study. During surgery, the classical fluoroscopy method (CFM) was used in 21 patients and the new fluoroscopy method (NFM) was used in the remaining 15 patients. Results The mean age was 5.14±1.13 years in the NFM group and 5.38±1.36 years in the CFM group. Mean operative time was 38.14±5.92 minutes in the CFM group and 21.54±3.48 minutes in the NFM group (p=0.001), while mean fluoroscopy times were 25.65±3.91 seconds and 39.84±7.50 seconds in the NFM and CFM groups, respectively (p=0.001). The NFM and CFM groups demonstrated similar functional capacity as measured by the Mayo Elbow Score (p=0.168). Direct radiographs obtained to measure Baumann’s angle also showed that the two groups had similar results (p=0.848). Conclusions The NFM is a reliable and successful technique as it leads to shorter operative and fluoroscopy times, as well as providing improvement in functional scores and radiological outcomes in short-term follow-up. Level of Evidence III, Therapeutic Studies-Investigating the Results Level of Treatment.
- Open Access
- 13 September 2021
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 28 (3) , 441-447
CLINICAL AND RADIOLOGICAL RESULTS OF TWO DIFFERENT PROXIMAL FEMUR NAILS USED IN THE TREATMENT OF INTERTROCHANTERIC FEMUR FRACTURES
Amaç Bu çalışmanın amacı iki farklı tipte proksimal femur çivisi (PFÇ) kullanılarak internal fiksasyon uygulanan intertrokanterik femur kırığı (İTK) olgularında fonksiyonel ve radyolojik sonuçların karşılaştırılmasıdır. Gereç ve Yöntem Bu çalışmada 1 Ocak 2012 – 31 Aralık 2018 tarihleri arasında kliniğimizde İTK nedeniyle ameliyat edilen hastaların dosyaları retrospektif olarak incelendi. Olgular uygulanan PFÇ tipine göre Profin ve İnterTan olmak üzere iki gruba ayrıldı. Bulgular 78 olgunun 41’i Profin, 37’si İnterTAN grubundaydı. Olguların %47,4’ü erkek, yaş ortalaması 74,12 ± 8,91’di. İnterTan grubu ile karşılaştırıldığında, Profin grubunda skopi süresi ve mobilizasyona kadar geçen süre istatistiksel olarak anlamlı düzeyde daha fazlaydı (sırasıyla, p = 0,002, p = 0,037). Profin grubu ile karşılaştırıldığında, İnterTan grubunda hastanede yatış süresi istatistiksel olarak anlamlı düzeyde daha fazlaydı (p = 0,001). Operasyondan bir yıl sonra değerlendirilen femur boyun açısı İnterTan grubunda istatistiksel olarak anlamlı düzeyde daha fazlaydı (p
- 13 September 2021
- Published by Medical Journal of Suleyman Demirel University in SDÜ Tıp Fakültesi Dergisi
- Vol. 28 (3) , 441-447
Open AccessCLINICAL AND RADIOLOGICAL RESULTS OF TWO DIFFERENT PROXIMAL FEMUR NAILS USED IN THE TREATMENT OF INTERTROCHANTERIC FEMUR FRACTURES
Amaç Bu çalışmanın amacı iki farklı tipte proksimal femur çivisi (PFÇ) kullanılarak internal fiksasyon uygulanan intertrokanterik femur kırığı (İTK) olgularında fonksiyonel ve radyolojik sonuçların karşılaştırılmasıdır. Gereç ve Yöntem Bu çalışmada 1 Ocak 2012 – 31 Aralık 2018 tarihleri arasında kliniğimizde İTK nedeniyle ameliyat edilen hastaların dosyaları retrospektif olarak incelendi. Olgular uygulanan PFÇ tipine göre Profin ve İnterTan olmak üzere iki gruba ayrıldı. Bulgular 78 olgunun 41’i Profin, 37’si İnterTAN grubundaydı. Olguların %47,4’ü erkek, yaş ortalaması 74,12 ± 8,91’di. İnterTan grubu ile karşılaştırıldığında, Profin grubunda skopi süresi ve mobilizasyona kadar geçen süre istatistiksel olarak anlamlı düzeyde daha fazlaydı (sırasıyla, p = 0,002, p = 0,037). Profin grubu ile karşılaştırıldığında, İnterTan grubunda hastanede yatış süresi istatistiksel olarak anlamlı düzeyde daha fazlaydı (p = 0,001). Operasyondan bir yıl sonra değerlendirilen femur boyun açısı İnterTan grubunda istatistiksel olarak anlamlı düzeyde daha fazlaydı (p
- Open Access
- 8 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Comparison of the Results of Hook Plate and Endo-Button Used in the Surgical Treatment of Acromioclavicular Joint Separation
Purpose: Our study aimed to compare the clinical outcomes between endo-button and hook plate fixations for the treatment of acute unstable acromioclavicular (AC) joint dislocation. Materials: A retrospective evaluation of patients with acute AC joint dislocation who were treated between February 2009 and December 2019 was performed. The study was conducted with 39 patients who met the inclusion criteria. Patients were divided into group I, operated with a hook plate, and group 2, operated with an endo-button. The demographic features and postoperative complications were analyzed. The disability of arm, shoulder, and hand (DASH) scoring system, modified University of California at Los Angeles shoulder score (UCLA) scale, and the visual analog scale (VAS) scores were used to evaluate shoulder functions in these patients. Shoulder functions were evaluated one, three, six, and twelve months after surgery. Results: There were 21 patients in group 1 and 18 patients in group 2. Gender distribution was 28 male and 11 female, and the average age was 30.9 years (18-50). There were no significant differences in age, sex, side of injury, or follow-up time from injury to surgery between the two groups. The UCLA scores of group 1 and group 2 one month after surgery were 17.2 and 27.2, respectively. DASH scores of group 1 and group 2 one month after surgery were 82 and 52, respectively. The VAS scores of group 1 and group 2 one month after surgery were 70 and 14, respectively. For all scores at first month post-surgery, there were statistically significant differences between groups, but scores became similar 12 months after surgery. Conclusion: Postoperative shoulder scores of patients with endo-button showed superiority in the early stages. However, after a year of follow-up, the results of the surgery performed with an endo-button or a hook plate were similar.
- 8 December 2020
- Published by Springer Nature in Cureus
- Vol. 12 (12)
Open AccessComparison of the Results of Hook Plate and Endo-Button Used in the Surgical Treatment of Acromioclavicular Joint Separation
Purpose: Our study aimed to compare the clinical outcomes between endo-button and hook plate fixations for the treatment of acute unstable acromioclavicular (AC) joint dislocation. Materials: A retrospective evaluation of patients with acute AC joint dislocation who were treated between February 2009 and December 2019 was performed. The study was conducted with 39 patients who met the inclusion criteria. Patients were divided into group I, operated with a hook plate, and group 2, operated with an endo-button. The demographic features and postoperative complications were analyzed. The disability of arm, shoulder, and hand (DASH) scoring system, modified University of California at Los Angeles shoulder score (UCLA) scale, and the visual analog scale (VAS) scores were used to evaluate shoulder functions in these patients. Shoulder functions were evaluated one, three, six, and twelve months after surgery. Results: There were 21 patients in group 1 and 18 patients in group 2. Gender distribution was 28 male and 11 female, and the average age was 30.9 years (18-50). There were no significant differences in age, sex, side of injury, or follow-up time from injury to surgery between the two groups. The UCLA scores of group 1 and group 2 one month after surgery were 17.2 and 27.2, respectively. DASH scores of group 1 and group 2 one month after surgery were 82 and 52, respectively. The VAS scores of group 1 and group 2 one month after surgery were 70 and 14, respectively. For all scores at first month post-surgery, there were statistically significant differences between groups, but scores became similar 12 months after surgery. Conclusion: Postoperative shoulder scores of patients with endo-button showed superiority in the early stages. However, after a year of follow-up, the results of the surgery performed with an endo-button or a hook plate were similar.
- 1 December 2020
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 46 (3) , 329-335
Comparison of Different Dynamization Techniques Applied in Cases of Tibial Fractures with Fracture Healing Problem after İntramedullary Nail Operation
Çalışmamızda intramedüller çivi (İMÇ) uygulanan tibia kırığı vakalarında dinamik kilitleme ve kaynama gecikmesi nedeniyle ikincil dinamizasyon uygulanan vakaları kaynama süreleri yönünden karşılaştırmak amaçlanmıştır. Mayıs 2002 ile Eylül 2019 tarihleri arasında tibia kırığı nedeniyle İMÇ kullanılarak kapalı redüksiyon internal fiksasyon uygulanan 95 hasta çalışmaya alındı. Hastalar dinamizasyon tekniklerine göre 3 gruba ayrıldı. Birinci grup dinamik kilitleme yapılan hastalar, ikinci grup dinamizasyon amacıyla sadece statik vida çıkarılan hastalar, 3. grup dinamizasyon amacıyla dinamik ve statik tüm vidalar çıkarılan hastalardı. Gruplar; demografik bilgiler, sigara kullanımı, kırık tipi ve kaynama süresi açısından karşılaştırmalı olarak değerlendirildi. Çalışmaya dahil edilen 95 hastanın 61’i erkek, 34’ü kadındı. Hastaların yaş ortalaması 35 (19 – 63) idi. Hastaların ortalama takip süresi 21,3 (12 – 30) hafta idi. Grup 2’de kaynama süresinin diğer gruplara göre daha uzun olduğu görüldü. Tüm hastalar ve ayrı ayrı gruplar arasında yaş ve cinsiyet ile kırık kaynama süresi arasında anlamlı istatistiksel bir ilişki saptanmamıştır (p>0.05). Tüm gruplar için sigara kullanan hastalarda kırık kaynama süresinin daha uzun olduğu saptanmıştır (p0.05). Gruplar, 12. haftadan tam kaynama gerçekleşene kadar geçen süreler açısından incelendiğinde grup 2’de istatistiksel olarak grup 3’ten daha uzun bir kaynama süresi olduğu saptandı (p
- 1 December 2020
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 46 (3) , 329-335
Comparison of Different Dynamization Techniques Applied in Cases of Tibial Fractures with Fracture Healing Problem after İntramedullary Nail Operation
Çalışmamızda intramedüller çivi (İMÇ) uygulanan tibia kırığı vakalarında dinamik kilitleme ve kaynama gecikmesi nedeniyle ikincil dinamizasyon uygulanan vakaları kaynama süreleri yönünden karşılaştırmak amaçlanmıştır. Mayıs 2002 ile Eylül 2019 tarihleri arasında tibia kırığı nedeniyle İMÇ kullanılarak kapalı redüksiyon internal fiksasyon uygulanan 95 hasta çalışmaya alındı. Hastalar dinamizasyon tekniklerine göre 3 gruba ayrıldı. Birinci grup dinamik kilitleme yapılan hastalar, ikinci grup dinamizasyon amacıyla sadece statik vida çıkarılan hastalar, 3. grup dinamizasyon amacıyla dinamik ve statik tüm vidalar çıkarılan hastalardı. Gruplar; demografik bilgiler, sigara kullanımı, kırık tipi ve kaynama süresi açısından karşılaştırmalı olarak değerlendirildi. Çalışmaya dahil edilen 95 hastanın 61’i erkek, 34’ü kadındı. Hastaların yaş ortalaması 35 (19 – 63) idi. Hastaların ortalama takip süresi 21,3 (12 – 30) hafta idi. Grup 2’de kaynama süresinin diğer gruplara göre daha uzun olduğu görüldü. Tüm hastalar ve ayrı ayrı gruplar arasında yaş ve cinsiyet ile kırık kaynama süresi arasında anlamlı istatistiksel bir ilişki saptanmamıştır (p>0.05). Tüm gruplar için sigara kullanan hastalarda kırık kaynama süresinin daha uzun olduğu saptanmıştır (p0.05). Gruplar, 12. haftadan tam kaynama gerçekleşene kadar geçen süreler açısından incelendiğinde grup 2’de istatistiksel olarak grup 3’ten daha uzun bir kaynama süresi olduğu saptandı (p
- Open Access
- 29 October 2020
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 25 (3) , 192-199
Comparison of Outcomes of Anterior Cruciate Ligament Reconstructions Using Patellar Tendon or Hamstring Tendon Autografts with Femoral Cross-pin Fixation
Tr en Amaç: Bu çalışmada femoral tarafta cross-pin fiksasyonu ile kemik–patellar tendon–kemik grefti (KPTG) veya hamstring tendon grefti (HTG) kullanılan ön çapraz bağ (ÖÇB) rekonstrüksiyonlarının sonuçlarını karşılaştırmak amaçlanmıştır. Gereç ve Yöntemler: Retrospektif gözlemsel çalışmamız Mayıs 2008—Ağustos 2012 döneminde femoral cross-pin fiksasyonlu ÖÇB rekonstrüksiyonu uygulanmış olan 100 hastanın kayıtlarını kapsadı. Hastalar, kullanılan greft türüne göre iki gruba ayrıldı: KPTG grubu ve HTG grubu. Preoperatif ve postoperatif 6. ay Tegner Lysholm Diz Skorlama Skalası (TLDS) skorları, Uluslararası Diz Dokümantasyon Komitesi Subjektif Diz Değerlendirme Formu (UDDK-SDF) skorları ve Lachman test sonuçları karşılaştırıldı. Ayrıca menisküs lezyonu varlığının sonuçlar üzerindeki etkisi incelendi. Bulgular: Yüz hastanın 93’ü erkek, 7’si kadındı. HTG ve KPTG grupları sırasıyla 62 ve 38 hastadan oluştu. Ortalama yaş HTG grubu için 24,1±4,9 (18–38) yıl, KPTG grubu için 32,1±6,8 (21–54) yıl idi. Sırasıyla operasyon öncesi ve sonrası ortalama TLDS skorları KPTG grubu için 50,5 ve 94,3, HTG grubu için 49,9 ve 95,2 idi. Operasyon öncesi ve sonrası ortalama UDDK-SDF skorları KPTG grubu için 51,3 ve 95,6, HTG grubu için 51,8 ve 95,6 idi. Postoperatif skorlardaki yükseliş tüm hastalarda istatistiksel olarak anlamlıydı (p<0,05); fakat iki grup arasında anlamlı fark yoktu. Diz stabilitesindeki postoperatif artış tüm hastalarda istatistiksel olarak anlamlıydı (p<0,05). Menisküs yaralanması olan hastalarda postoperatif skorlardaki yükseliş daha azdı (p<0,05). Tartışma ve Sonuç: İki grup arasında fonksiyonel diz skorları açısından anlamlı bir fark tespit edilmemiştir. Fakat menisküs lezyonu varlığı postoperatif sonuçları negatif etkilemektedir. Aim: In this study, we aimed to compare outcomes of anterior cruciate ligament (ACL) reconstructions using bone–patellar tendon–bone graft (BPTG) or hamstring tendon graft (HTG) with cross-pin fixation at the femoral side. Materials and Methods: The retrospective observational study included records of 100 patients who underwent ACL reconstruction with femoral cross-pin fixation between May 2008 and August 2012. The patients were divided into two groups according to the graft type used: the BPTG group and the HTG group. The preoperative and postoperative 6th-month Tegner Lysholm Knee Scoring Scale (TLKS) scores, International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC-SKF) scores, and Lachman test results were compared. The effects of meniscus lesion presence on the outcomes were also investigated. Results: Of the 100 patients, 93 were male and 7 female. The HTG and BPTG groups consisted of 62 and 38 patients, respectively. The mean age was 24.1±4.9 (18–38) years for the HTG group and 32.1±6.8 (21–54) years for the BPTG group. The mean pre- and postoperative TLKS scores were respectively 50.5 and 94.3 in the BPTG group, and 49.9 and 95.2 in the HTG group. The mean pre- and postoperative IKDC-SKF scores were 51.3 and 95.6 in the BPTG group, and 51.8 and 95.6 in the HTG group. The postoperative score improvement was statistically significant in all patients (p<0.05), but there was no significant difference between the two groups. The postoperative improvement in knee stability was statistically significant in all patients (p<0.05). The postoperative score improvement was less in patients with meniscal injury (p<0.05). Discussion and Conclusion: We found no significant difference between the two groups in terms of functional knee scores. However, the presence of meniscus lesions negatively affects the postoperative outcomes.
- 29 October 2020
- Published by Anadolu Klinigi Tip Bilimleri Dergisi in Anadolu Kliniği Tıp Bilimleri Dergisi
- Vol. 25 (3) , 192-199
Open AccessComparison of Outcomes of Anterior Cruciate Ligament Reconstructions Using Patellar Tendon or Hamstring Tendon Autografts with Femoral Cross-pin Fixation
Tr en Amaç: Bu çalışmada femoral tarafta cross-pin fiksasyonu ile kemik–patellar tendon–kemik grefti (KPTG) veya hamstring tendon grefti (HTG) kullanılan ön çapraz bağ (ÖÇB) rekonstrüksiyonlarının sonuçlarını karşılaştırmak amaçlanmıştır. Gereç ve Yöntemler: Retrospektif gözlemsel çalışmamız Mayıs 2008—Ağustos 2012 döneminde femoral cross-pin fiksasyonlu ÖÇB rekonstrüksiyonu uygulanmış olan 100 hastanın kayıtlarını kapsadı. Hastalar, kullanılan greft türüne göre iki gruba ayrıldı: KPTG grubu ve HTG grubu. Preoperatif ve postoperatif 6. ay Tegner Lysholm Diz Skorlama Skalası (TLDS) skorları, Uluslararası Diz Dokümantasyon Komitesi Subjektif Diz Değerlendirme Formu (UDDK-SDF) skorları ve Lachman test sonuçları karşılaştırıldı. Ayrıca menisküs lezyonu varlığının sonuçlar üzerindeki etkisi incelendi. Bulgular: Yüz hastanın 93’ü erkek, 7’si kadındı. HTG ve KPTG grupları sırasıyla 62 ve 38 hastadan oluştu. Ortalama yaş HTG grubu için 24,1±4,9 (18–38) yıl, KPTG grubu için 32,1±6,8 (21–54) yıl idi. Sırasıyla operasyon öncesi ve sonrası ortalama TLDS skorları KPTG grubu için 50,5 ve 94,3, HTG grubu için 49,9 ve 95,2 idi. Operasyon öncesi ve sonrası ortalama UDDK-SDF skorları KPTG grubu için 51,3 ve 95,6, HTG grubu için 51,8 ve 95,6 idi. Postoperatif skorlardaki yükseliş tüm hastalarda istatistiksel olarak anlamlıydı (p<0,05); fakat iki grup arasında anlamlı fark yoktu. Diz stabilitesindeki postoperatif artış tüm hastalarda istatistiksel olarak anlamlıydı (p<0,05). Menisküs yaralanması olan hastalarda postoperatif skorlardaki yükseliş daha azdı (p<0,05). Tartışma ve Sonuç: İki grup arasında fonksiyonel diz skorları açısından anlamlı bir fark tespit edilmemiştir. Fakat menisküs lezyonu varlığı postoperatif sonuçları negatif etkilemektedir. Aim: In this study, we aimed to compare outcomes of anterior cruciate ligament (ACL) reconstructions using bone–patellar tendon–bone graft (BPTG) or hamstring tendon graft (HTG) with cross-pin fixation at the femoral side. Materials and Methods: The retrospective observational study included records of 100 patients who underwent ACL reconstruction with femoral cross-pin fixation between May 2008 and August 2012. The patients were divided into two groups according to the graft type used: the BPTG group and the HTG group. The preoperative and postoperative 6th-month Tegner Lysholm Knee Scoring Scale (TLKS) scores, International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC-SKF) scores, and Lachman test results were compared. The effects of meniscus lesion presence on the outcomes were also investigated. Results: Of the 100 patients, 93 were male and 7 female. The HTG and BPTG groups consisted of 62 and 38 patients, respectively. The mean age was 24.1±4.9 (18–38) years for the HTG group and 32.1±6.8 (21–54) years for the BPTG group. The mean pre- and postoperative TLKS scores were respectively 50.5 and 94.3 in the BPTG group, and 49.9 and 95.2 in the HTG group. The mean pre- and postoperative IKDC-SKF scores were 51.3 and 95.6 in the BPTG group, and 51.8 and 95.6 in the HTG group. The postoperative score improvement was statistically significant in all patients (p<0.05), but there was no significant difference between the two groups. The postoperative improvement in knee stability was statistically significant in all patients (p<0.05). The postoperative score improvement was less in patients with meniscal injury (p<0.05). Discussion and Conclusion: We found no significant difference between the two groups in terms of functional knee scores. However, the presence of meniscus lesions negatively affects the postoperative outcomes.
- Open Access
- 1 August 2020
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 4 (8) , 645-648
Evaluation of axillary nerve integrity and shoulder functions in patients who underwent lateral deltoid splitting approach
Aim: The most common complication of the Lateral deltoid splitting approach (LDSA), which is used in the shoulder area, especially for posterior extension fractures and other soft tissue pathologies, is axillary nerve injury. Determining the frequency of nerve injuries that may occur after LDSA is decisive for the applicability of this approach. Therefore, in our study, we aimed to evaluate the axillary nerve integrity and shoulder functions in patients who underwent LDSA. Methods: In this prospective cohort study, 55 patients who were operated with LDSA for proximal humerus fractures between February 2015 and July 2018 were evaluated. Among these patients, 35 were selected and included in the study. Six months later Electrophysiological tests (Electroneuromyelography – ENMG) and Constant Shoulder Score (CSS) were used for evaluation of each operated and non-operated shoulder. CSS difference between the operated and non-operated sides was graded as mild (11-20 point), moderate (21-30) and severe (>30). Results: Mean age of the group was 66 (9) years. Twenty-five patients were female and 10 were male. Mean follow-up time was 4 (1) years. Mean latencies of axillary nerve were 4.6 (1.8) msn, 3.7 (0.54) msn and mean amplitudes of axillary nerve were 6.6 (2.21) mV, 8.4 (2.80) mV in the operated and non-operated shoulders, respectively. There was no statically significant difference between the operated and non-operated sides according to latency and amplitude (latency P=0.25, amplitude P=0.16). Mean CSS of the patients were 28.7. CSS of 12 patients were severe (mean: 39.08), 18 patients, moderate (mean 25.4) and 5 patients, mild (mean 16). There was no statically significant correlation between CSS and axillary nerve latency / amplitude (P= 0.62, r=0.267 / P=0.98, r=-0.339). Fracture type and CSS showed a statically significant correlation (P=0.032, r= 0.829). Conclusion: This study revealed that LDSA provides wide and versatile fracture control without compromising the deltoid muscle functions and axillary nerve, especially in fractures extending to the posterior part of the proximal humerus. '+st+' Buecking B, Mohr J, Bockmann B, Zettl R, Ruchholtz S. Deltoid-split or deltopectoral approaches for the treatment of displaced proximal humeral fractures? Clin Orthop Relat Res. 2014;472:1576–85. doi:10.1007/s11999-013-3415-7. Hoppenfeld S. deBoer P. Surgical exposures. Philadelphia: Lippincott, Williams and Wilkins; 2003. Saran N, Bergeron SG, Benoit B, Reindl R, Harvey EJ, Berry GK. Risk of axillary nerve injury during percutaneous proximal humerus locking plate insertion using an external aiming guide. Injury. 2010;41:1037–40. doi:10.1016/j.injury.2010.04.014. Gardner MJ, Voos JE, Wanich T, Helfet DL, Lorich DG. Vascular implications of minimally invasive plating of proximal humerus fractures. J Orthop Trauma. 2006;20:602–7. doi:10.1097/01.bot.0000246412.10176.14. Gerber C, Werner CML, Vienne P. Internal fixation of complex fractures of the proximal humerus. J Bone Joint Surg - Series B. 2004;86:848–55. doi:10.1302/0301-620X.86B6.14577. Kayaokay K, Mirzazade C, Küçük L, Coşkunol E. Comparison of open acromioplasty outcomes according to approach type; anterior and lateral. J Surg Med. 2017;1:49–51. doi:10.28982/josam.351717. Perlmutter GS. Axillary nerve injury. In: Clin Orthop Relat Res. Lippincott Williams and Wilkins; 1999. p. 28–36. doi:10.1097/00003086-199911000-00005. Gurushantappa PK, Kuppasad S. Anatomy of axillary nerve and its clinical importance: a cadaveric study. J Clin Diagn Res. 2015 Mar;93:13-7. Constant CR, Murley AHG. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987;214:160–4. Westphal T, Woischnik S, Adolf D, Feistner H, Piatek S. Axillary nerve lesions after open reduction and internal fixation of proximal humeral fractures through an extended lateral deltoid-split approach: electrophysiological findings. J Shoulder Elb Surg. 2017;26:464–71. doi:10.1016/j.jse.2016.07.027. Singh H, Batra A, Patel D. Lateral transdeltoid approach to proximal humerus fractures. Int Surg J. 2015;2:337–40. doi:10.18203/2349-2902.isj20150400. Robinson CM, Murray IR. The extended deltoid-splitting approach to the proximal humerus: Variations and extensions. J Bone Joint Surg. 2011;93 B:387–92. doi:10.1302/0301-620X.93B3.25818. Wu CH, Ma CH, Yeh JJH, Yen CY, Yu SW, Tu YK. Locked plating for proximal humeral fractures: Differences between the deltopectoral and deltoid-splitting approaches. J Trauma. 2011;71:1364–70. doi:10.1097/TA.0b013e31820d165d. Gardner MJ, Griffith MH, Dines JS, Briggs SM, Weiland AJ, Lorich DG. The extended anterolateral acromial approach allows minimally invasive access to the proximal humerus. Clin Orthop Relat Res. 2005;123–9. doi:10.1097/01.blo.0000152872.95806.09. Khan LAK, Robinson CM, Will E, Whittaker R. Assessment of axillary nerve function and functional outcome after fixation of complex proximal humeral fractures using the extended deltoid-splitting approach. Injury. 2009;40:181–5. doi:10.1016/j.injury.2008.05.031. Isiklar Z, Kormaz F, Gogus A, Kara A. Comparision of deltopectoral versus lateral deltoid split approach in operative treatment of proximal humeral fractures. J Bone Joint Surg Br. 2010;92:352. Cheung S, Fitzpatrick M, Lee TQ. Effects of shoulder position on axillary nerve positions during the split lateral deltoid approach. J Shoulder Elbow Surg. 2009;18:748–55. doi:10.1016/j.jse.2008.12.001. Laflamme GY, Rouleau DM, Berry GK, Beaumont PH, Reindl R, Harvey EJ. Percutaneous humeral plating of fractures of the proximal humerus: Results of a prospective multicenter clinical trial. J Orthop Trauma. 2008;22:153–8. doi:10.1097/BOT.0b013e3181694f7d. Robinson CM, Stirling PHC, Goudie EB, Macdonald DJ, Strelzow JA. Complications and Long-Term Outcomes of Open Reduction and Plate Fixation of Proximal...
- 1 August 2020
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 4 (8) , 645-648
Open AccessEvaluation of axillary nerve integrity and shoulder functions in patients who underwent lateral deltoid splitting approach
Aim: The most common complication of the Lateral deltoid splitting approach (LDSA), which is used in the shoulder area, especially for posterior extension fractures and other soft tissue pathologies, is axillary nerve injury. Determining the frequency of nerve injuries that may occur after LDSA is decisive for the applicability of this approach. Therefore, in our study, we aimed to evaluate the axillary nerve integrity and shoulder functions in patients who underwent LDSA. Methods: In this prospective cohort study, 55 patients who were operated with LDSA for proximal humerus fractures between February 2015 and July 2018 were evaluated. Among these patients, 35 were selected and included in the study. Six months later Electrophysiological tests (Electroneuromyelography – ENMG) and Constant Shoulder Score (CSS) were used for evaluation of each operated and non-operated shoulder. CSS difference between the operated and non-operated sides was graded as mild (11-20 point), moderate (21-30) and severe (>30). Results: Mean age of the group was 66 (9) years. Twenty-five patients were female and 10 were male. Mean follow-up time was 4 (1) years. Mean latencies of axillary nerve were 4.6 (1.8) msn, 3.7 (0.54) msn and mean amplitudes of axillary nerve were 6.6 (2.21) mV, 8.4 (2.80) mV in the operated and non-operated shoulders, respectively. There was no statically significant difference between the operated and non-operated sides according to latency and amplitude (latency P=0.25, amplitude P=0.16). Mean CSS of the patients were 28.7. CSS of 12 patients were severe (mean: 39.08), 18 patients, moderate (mean 25.4) and 5 patients, mild (mean 16). There was no statically significant correlation between CSS and axillary nerve latency / amplitude (P= 0.62, r=0.267 / P=0.98, r=-0.339). Fracture type and CSS showed a statically significant correlation (P=0.032, r= 0.829). Conclusion: This study revealed that LDSA provides wide and versatile fracture control without compromising the deltoid muscle functions and axillary nerve, especially in fractures extending to the posterior part of the proximal humerus. '+st+' Buecking B, Mohr J, Bockmann B, Zettl R, Ruchholtz S. Deltoid-split or deltopectoral approaches for the treatment of displaced proximal humeral fractures? Clin Orthop Relat Res. 2014;472:1576–85. doi:10.1007/s11999-013-3415-7. Hoppenfeld S. deBoer P. Surgical exposures. Philadelphia: Lippincott, Williams and Wilkins; 2003. Saran N, Bergeron SG, Benoit B, Reindl R, Harvey EJ, Berry GK. Risk of axillary nerve injury during percutaneous proximal humerus locking plate insertion using an external aiming guide. Injury. 2010;41:1037–40. doi:10.1016/j.injury.2010.04.014. Gardner MJ, Voos JE, Wanich T, Helfet DL, Lorich DG. Vascular implications of minimally invasive plating of proximal humerus fractures. J Orthop Trauma. 2006;20:602–7. doi:10.1097/01.bot.0000246412.10176.14. Gerber C, Werner CML, Vienne P. Internal fixation of complex fractures of the proximal humerus. J Bone Joint Surg - Series B. 2004;86:848–55. doi:10.1302/0301-620X.86B6.14577. Kayaokay K, Mirzazade C, Küçük L, Coşkunol E. Comparison of open acromioplasty outcomes according to approach type; anterior and lateral. J Surg Med. 2017;1:49–51. doi:10.28982/josam.351717. Perlmutter GS. Axillary nerve injury. In: Clin Orthop Relat Res. Lippincott Williams and Wilkins; 1999. p. 28–36. doi:10.1097/00003086-199911000-00005. Gurushantappa PK, Kuppasad S. Anatomy of axillary nerve and its clinical importance: a cadaveric study. J Clin Diagn Res. 2015 Mar;93:13-7. Constant CR, Murley AHG. A clinical method of functional assessment of the shoulder. Clin Orthop Relat Res. 1987;214:160–4. Westphal T, Woischnik S, Adolf D, Feistner H, Piatek S. Axillary nerve lesions after open reduction and internal fixation of proximal humeral fractures through an extended lateral deltoid-split approach: electrophysiological findings. J Shoulder Elb Surg. 2017;26:464–71. doi:10.1016/j.jse.2016.07.027. Singh H, Batra A, Patel D. Lateral transdeltoid approach to proximal humerus fractures. Int Surg J. 2015;2:337–40. doi:10.18203/2349-2902.isj20150400. Robinson CM, Murray IR. The extended deltoid-splitting approach to the proximal humerus: Variations and extensions. J Bone Joint Surg. 2011;93 B:387–92. doi:10.1302/0301-620X.93B3.25818. Wu CH, Ma CH, Yeh JJH, Yen CY, Yu SW, Tu YK. Locked plating for proximal humeral fractures: Differences between the deltopectoral and deltoid-splitting approaches. J Trauma. 2011;71:1364–70. doi:10.1097/TA.0b013e31820d165d. Gardner MJ, Griffith MH, Dines JS, Briggs SM, Weiland AJ, Lorich DG. The extended anterolateral acromial approach allows minimally invasive access to the proximal humerus. Clin Orthop Relat Res. 2005;123–9. doi:10.1097/01.blo.0000152872.95806.09. Khan LAK, Robinson CM, Will E, Whittaker R. Assessment of axillary nerve function and functional outcome after fixation of complex proximal humeral fractures using the extended deltoid-splitting approach. Injury. 2009;40:181–5. doi:10.1016/j.injury.2008.05.031. Isiklar Z, Kormaz F, Gogus A, Kara A. Comparision of deltopectoral versus lateral deltoid split approach in operative treatment of proximal humeral fractures. J Bone Joint Surg Br. 2010;92:352. Cheung S, Fitzpatrick M, Lee TQ. Effects of shoulder position on axillary nerve positions during the split lateral deltoid approach. J Shoulder Elbow Surg. 2009;18:748–55. doi:10.1016/j.jse.2008.12.001. Laflamme GY, Rouleau DM, Berry GK, Beaumont PH, Reindl R, Harvey EJ. Percutaneous humeral plating of fractures of the proximal humerus: Results of a prospective multicenter clinical trial. J Orthop Trauma. 2008;22:153–8. doi:10.1097/BOT.0b013e3181694f7d. Robinson CM, Stirling PHC, Goudie EB, Macdonald DJ, Strelzow JA. Complications and Long-Term Outcomes of Open Reduction and Plate Fixation of Proximal...